Toremifene for Reduction of fractures and other Estrogen deficiency side effects in men on Androgen deprivation Therapy 2.
Withdrawn prior to enrolment
Phase of Trial: Phase III
Latest Information Update: 14 Nov 2013
At a glance
- Drugs Toremifene (Primary)
- Indications Fracture; Male osteoporosis; Prostate cancer
- Focus Registrational; Therapeutic Use
- Acronyms TREAT-2
- Sponsors GTx
- 09 May 2011 Status changed from not yet recruiting to withdrawn prior to recruitment - trial withdrawn prior to recruitment prior to enrolment
- 05 Oct 2010 Additional lead trial centre, investigator trial sponser identified as reported by ClinicalTrials.gov.
- 05 Oct 2010 New source identified and integrated (ClinicalTrials.gov: US National Institutes of Health).